North America
|
 |
Europe/Asia
|
 Michael
Steiner
Michael Steiner is a partner in our Boston office.
Following a career spanning 25 years of international
experience in the pharmaceutical, biotech and
medical technology industries, Dr. Steiner's focus
is on M&A transactions, investments, private
equity projects, strategy development and turn-around
situations of companies. |
|
 Wolfgang
Stoiber
Wolfgang Stoiber is a co-founder and partner based
in our Munich office. Dr. Stoiber has over 25
years of experience as a physician, pharmaceutical
industry executive and as an investment banker. |
|
|
|
 T.Scott
Johnson
Scott Johnson is a co-founder and partner based
in our Boston office. Drawing on 30 years of experience
as a physician and 17 years as a transaction advisor,
Dr. Johnson has executed a wide range of transactions
for pharmaceutical and biotechnology companies,
North American and European venture capital firms,
and private investors. |
|
 Ulrich
Pessara
Ulrich Pessara is a partner based in our Munich
office. With more than 22 years experience, Dr. Pessara
combines unique expertise as a scientist with extensive
business, operational and financial experience in the
pharmaceutical and biotech industries. |
|
|
|
 Ton Bunt
Ton Bunt is a senior advisor in our Boston office. Following a career spanning over 21 years of international experience as a physician and pharmaceutical industry executive, Dr. Bunt's focus is now on clinical development, product commercialization, and licensing. |
|
 Michel
Gouy
Michel Gouy is a partner focused on the European
business. Mr. Gouy has been active for more than
24 years in the life science industries, specializing
in strategic planning, sales and marketing, and
international management. |
|
|
|
 Richard Page
Richard Page is a Senior Advisor in our Boston office. Mr. Page has over over 13 years experience as a life sciences investment banker working on over $9 billion of financing and M&A transactions.
|
|
 Klaus May
Klaus May is a Senior Advisor focused on the Asian business working out of Tokyo. Dr. May has been active in the life sciences for more than 18 years specializing in management consulting, investment banking and as entrepreneur. Dr. May is experienced in cross border M&A transactions, private equity projects, growth strategy and turn-around of companies. |
|
|
|
 Abbas Kazimi
Abbas Kazimi is an analyst in our Boston office. He is responsible for managing client relationships and evaluating products for potential partnerships. With a background in molecular biology and biotechnology, Mr. Kazimi is also responsible for conducting financial analysis, completing due diligence, and facilitating negotiations. |
| |
|
|
|
 Matthew Farley
Matthew Farley is an analyst in our Boston office. He is responsible for analytical work and transaction support for the JSB-Partners team. With a background in Biochemistry, Mr. Farley conducts financial and company analysis, assists in due diligence, and supports negotiations. |
| |
|
|
|
